Published: 16-12-2022 10:29 | Updated: 16-12-2022 10:29
Don't miss the last morning coffee meeting of the year with Center of Alzheimer Research
Bengt Winblad, Per Nilsson, Maria Ankarcrona, Division of Neurogeriatrics.
Photo: Selma Wolofsky och Annika Clemes
Report from ClinicaL Trials on Alzheimer's Desease 2022 - ”Positive clinical outcome of Lecanemab immunotherapy and other promising therapeutic approaches for Alzheimer’s"
Bengt Winblad, Per Nilsson and Maria Ankarcrona, Division of Neurogeriatrics reports from the recent conference in San Fransisco.
You are welcome to join via Zoom:
https://ki-se.zoom.us/j/67605015526?pwd=NC8zMzB0NG9ZbDhIMUh4QzY1aURqUT09